- Home
- CCLD vs XGN Comparison
CCLD vs XGN Comparison
Compare CCLD & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCLD
- XGN
- Stock Information
- Founded
- CCLD 1999
- XGN 2002
- Country
- CCLD United States
- XGN United States
- Employees
- CCLD N/A
- XGN N/A
- Industry
- CCLD Computer Software: Prepackaged Software
- XGN Medical Specialities
- Sector
- CCLD Technology
- XGN Health Care
- Exchange
- CCLD Nasdaq
- XGN Nasdaq
- Market Cap
- CCLD 157.0M
- XGN 138.3M
- IPO Year
- CCLD 2014
- XGN 2019
- Fundamental
- Price
- CCLD $3.84
- XGN $9.86
- Analyst Decision
- CCLD Buy
- XGN Strong Buy
- Analyst Count
- CCLD 2
- XGN 4
- Target Price
- CCLD $3.00
- XGN $11.75
- AVG Volume (30 Days)
- CCLD 710.7K
- XGN 224.1K
- Earning Date
- CCLD 08-05-2025
- XGN 07-29-2025
- Dividend Yield
- CCLD N/A
- XGN N/A
- EPS Growth
- CCLD N/A
- XGN N/A
- EPS
- CCLD 0.00
- XGN N/A
- Revenue
- CCLD $111,794,000.00
- XGN $58,862,000.00
- Revenue This Year
- CCLD $2.20
- XGN $22.09
- Revenue Next Year
- CCLD $7.53
- XGN $13.62
- P/E Ratio
- CCLD $5,558.78
- XGN N/A
- Revenue Growth
- CCLD 0.04
- XGN 3.89
- 52 Week Low
- CCLD $1.14
- XGN $2.38
- 52 Week High
- CCLD $4.84
- XGN $10.34
- Technical
- Relative Strength Index (RSI)
- CCLD 84.28
- XGN 65.41
- Support Level
- CCLD $2.54
- XGN $9.45
- Resistance Level
- CCLD $4.01
- XGN $10.34
- Average True Range (ATR)
- CCLD 0.19
- XGN 0.45
- MACD
- CCLD 0.13
- XGN -0.07
- Stochastic Oscillator
- CCLD 85.62
- XGN 66.55
About CCLD CareCloud Inc.
CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.